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ABSTRACT Herpesviruses, which include important pathogens, remodel the host cell nucleus to facilitate infection. This remod-
eling includes the formation of structures called replication compartments (RCs) in which herpesviruses replicate their DNA.
During infection with the betaherpesvirus, human cytomegalovirus (HCMV), viral DNA synthesis occurs at the periphery of RCs
within the nuclear interior, after which assembled capsids must reach the inner nuclear membrane (INM) for translocation to
the cytoplasm (nuclear egress). The processes that facilitate movement of HCMV capsids to the INM during nuclear egress are
unknown. Although an actin-based mechanism of alphaherpesvirus capsid trafficking to the INM has been proposed, it is con-
troversial. Here, using a fluorescently-tagged, nucleus-localized actin-binding peptide, we show that HCMV, but not herpes sim-
plex virus 1, strongly induced nuclear actin filaments (F-actin) in human fibroblasts. Based on studies using UV inactivation and
inhibitors, this induction depended on viral gene expression. Interestingly, by 24 h postinfection, nuclear F-actin formed thicker
structures that appeared by super-resolutionmicroscopy to be bundles of filaments. Later in infection, nuclear F-actin primarily
localized along the RC periphery and between the RC periphery and the nuclear rim. Importantly, a drug that depolymerized
nuclear F-actin caused defects in production of infectious virus, capsid accumulation in the cytoplasm, and capsid localization
near the nuclear rim, without decreasing capsid accumulation in the nucleus. Thus, our results suggest that for at least one her-
pesvirus, nuclear F-actin promotes capsid movement to the nuclear periphery and nuclear egress. We discuss our results in
terms of competing models for these processes.
IMPORTANCE Themechanisms underlying herpesvirus nuclear egress have not been fully determined. In particular, how newly
assembled capsids move to the inner nuclear membrane for envelopment is uncertain and controversial. In this study, we show
that HCMV, an important human pathogen, induces actin filaments in the nuclei of infected cells and that an inhibitor of nu-
clear F-actin impairs nuclear egress and capsid localization toward the nuclear periphery. Herpesviruses are widespread patho-
gens that cause or contribute to an array of human diseases. A better understanding of how herpesvirus capsids traffic in the nu-
cleus may uncover novel targets for antiviral intervention and elucidate aspects of the nuclear cytoskeleton, about which little is
known.
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Herpesviruses execute important steps of their replicationcycles in the host cell nucleus. Among these steps is viral
DNA synthesis, which occurs in discrete structures called rep-
lication compartments (RCs). Assembled capsids are then
packaged with DNA before they translocate from the nucleus to
the cytoplasm in a process called nuclear egress. To facilitate
these steps, herpesviruses impart profound changes to host nu-
clear architecture, including the formation and expansion of
RCs, partitioning of host chromatin, and disruption of the nu-
clear lamina (1).
Human cytomegalovirus (HCMV) is a betaherpesvirus that is
an important pathogen in immunocompromised and immune-
naive individuals (2). During infection with HCMV, viral DNA
synthesis occurs away from the nuclear rim at the periphery of RCs
(3–6). The presence of capsid and terminase proteins in RCs sug-
gests that capsid assembly and packaging are spatially coordinated
with DNA synthesis within the nuclear interior (7–12). Assembly
and packaging are followed by nuclear egress, which includes
movement of capsids to the nuclear rim, disruption of the nuclear
lamina, capsid envelopment at the inner nuclear membrane (pri-
mary envelopment), and finally deenvelopment at the outer nu-
clear membrane (13, 14). While much progress has been made
toward understanding events at the nuclear rim (13, 15–23), very
little is known about earlier steps of nuclear egress. Specifically,
how HCMV capsids move from RCs to the nuclear periphery for
primary envelopment is unknown.
Several studies have suggested roles for nuclear actin filaments
(F-actin) during alphaherpesvirus infection. One study showed
that herpes simplex virus 1 (HSV-1) RCs move in a manner that
was antagonized by inhibitors of F-actin and myosin (24). It has
also been reported that infection with pseudorabies virus (PRV)
or HSV-1 induces nuclear F-actin in neuronal cells and that cap-
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sids colocalize with actin filaments and a myosin motor protein
(25). Using particle tracking analysis, another group found di-
rected intranuclear movements of HSV-1 capsids that were antag-
onized by ATP depletion or by inhibitors of myosin and F-actin
(26). Despite these reports, the notion that a nuclear F-actin-
based mechanism facilitates herpesvirus capsid motility has re-
cently been challenged by Bosse et al. (27, 28). This group was
unable to visualize actin filaments in the nuclei of murine em-
bryonic fibroblasts (MEFs) infected with PRV, HSV-1, mouse
cytomegalovirus (MCMV), and murine gammaherpesvirus 68
(MHV-68) (27). They also reported that alphaherpesvirus
(PRV and HSV-1) infection alters chromatin domains so that
capsids can efficiently move by diffusion rather than by a di-
rected mechanism to the nuclear periphery (28). Regardless,
whether nuclear F-actin is induced or has any role during
HCMV infection, or whether F-actin plays a role in nuclear
egress per se for any herpesvirus, has not been reported. Further
investigation into the importance of the nuclear cytoskeleton
for herpesvirus infection is important not only for virology but
also for cell biology, as the functions of nuclear F-actin remain
largely unexplored.
In the present study, we began by asking whether nuclear actin
filaments are present in HCMV-infected cells. We observed a
striking induction of nuclear F-actin in HCMV-, but not HSV-1-,
infected human fibroblasts. Induction of nuclear F-actin began
early in infection and relied on viral gene expression. Examination
of nuclear F-actin localization relative to RCs revealed that fila-
ments localized along the periphery of RCs and extended between
the RC periphery and the nuclear rim. Crucially, an inhibitor that
depolymerizes nuclear F-actin caused defects in the production of
infectious virus, capsid accumulation in the cytoplasm, and capsid
localization toward the nuclear periphery. We discuss the impli-
cations of our results for competing models by which nuclear
F-actin would abet movement of capsids from RCs to the nuclear
rim.
RESULTS
Induction of nuclear F-actin during HCMV infection. To deter-
mine whether nuclear F-actin is present in HCMV-infected cells,
we utilized LifeAct-green fluorescent protein (GFP), an actin-
binding peptide that has been extensively used to visualize F-actin
and does not interfere with its dynamics in vitro or in vivo (29). To
more easily discern filaments in the nucleus, we generated human
foreskin fibroblasts (HFFs) stably expressing LifeAct-GFP fused to
a nuclear localization signal (LifeAct-GFP-NLS) that has previ-
ously been used to visualize nuclear F-actin (30, 31). LifeAct-GFP-
NLS-expressing HFFs were either mock infected or infected with
wild-type (WT) HCMV (multiplicity of infection [MOI] of 1).
Cells were stained with 4=,6-diamidino-2-phenylindole (DAPI) to
visualize nuclei, and infected nuclei were additionally marked by
staining with antibodies against HCMV IE 1/2 proteins. During
mock infection, the vast majority of cells (93%, n  118) con-
tained diffuse LifeAct-GFP-NLS primarily, but not exclusively, in
the nucleus, with no nuclear F-actin apparent (Fig. 1, row i). How-
ever, a small minority of cells (7%) displayed a network of what
appeared to be individual nuclear actin filaments (Fig. 1, row ii).
These results are consistent with previous reports that nuclear
F-actin can form in some uninfected cells (30–33). In contrast,
nuclear F-actin was induced in LifeAct-GFP-NLS-expressing
HFFs infected with HCMV starting around 6 h postinfection (hpi)
(see Movie S1 in the supplemental material), with 88% (n 25) of
infected cells at 8 hpi, 92% (n 110) at 24 hpi, and 74% (n 86)
at 72 hpi containing nuclear F-actin (examples in Fig. 1, rows iii to
v). Interestingly, by 24 hpi, most filaments formed thicker struc-
tures (Fig. 1A, rows iv and v; also see Movie S1). To better resolve
these thicker structures, we utilized super-resolution three-
dimensional structured illumination microscopy (3D-SIM) and
found what appeared to be bundled F-actin filaments at various
orientations throughout the nuclear volume (see Movie S2). Fi-
nally, as it has been reported that alphaherpesvirus capsids colo-
calize with virus-induced nuclear F-actin (25), we investigated
whether an HCMV capsid protein (major capsid protein [MCP])
would colocalize with nuclear actin filaments. At 72 hpi, we ob-
served colocalization of actin filaments and MCP in the nucleus
(see Fig. S1).
We wondered whether HSV-1 would similarly induce nuclear
F-actin in HFFs. To explore this possibility, LifeAct-GFP-NLS-
expressing HFFs were infected with HSV-1 encoding the VP26
capsid protein fused to red fluorescent protein (VP26-RFP; MOI
of 3), thus marking infected cells. We observed that the vast ma-
jority of HSV-1-infected cells displayed only diffuse LifeAct-GFP-
NLS in the nucleus at both 8 hpi (94%, n 84) and 18 hpi (87%,
n 93) (Fig. 2). In the small number of HSV-1-infected cells that
did contain nuclear F-actin, filaments appeared shorter and thin-
ner than in HCMV-infected cells and did not colocalize meaning-
fully with VP26-RFP (see Fig. S2 in the supplemental material).
Thus, HSV-1 and HCMV differ in their capacity to induce nuclear
F-actin in HFFs.
Herpesviruses are known to disrupt cytoplasmic F-actin
stress fibers (34–36); thus, we asked whether the LifeAct-GFP-
NLS induces nuclear F-actin by “dragging” monomeric
G-actin into the nucleus. To examine this possibility, LifeAct-
GFP-NLS-expressing HFFs were either mock infected or in-
fected with WT HCMV, and lysates were separated into nuclear
and cytoplasmic fractions. Using Western blot analysis, we
confirmed successful fractionation based on the distribution of
lamin B and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) but were unable to detect an increase in either
-actin or LifeAct-GFP-NLS levels in the nucleus during infec-
tion, suggesting that HCMV likely induces nuclear F-actin
from a preexisting pool of monomeric nuclear G-actin (see
Fig. S3 in the supplemental material).
Determinants of nuclear F-actin induction. Given that nu-
clear F-actin is induced starting around 6 h following HCMV in-
fection, we hypothesized that either virion structural proteins
and/or immediate early gene expression is responsible for induc-
tion. To discriminate between these possibilities, we infected
LifeAct-GFP-NLS-expressing HFFs with UV-inactivated or
mock-UV-inactivated WT HCMV (MOI of 1), fixed cells at
24 hpi, and stained cells with DAPI and with anti-IE 1/2 antibod-
ies. Fluorescence microscopy revealed that UV inactivation sub-
stantially reduced IE 1/2 gene expression, as expected, and greatly
reduced the percentage of cells containing nuclear F-actin, sug-
gesting that functional viral genes are required for induction,
while virion structural proteins are not sufficient for induction
(Fig. 3A, rows i and ii, and B). Similarly, inhibition of protein
synthesis with cycloheximide drastically reduced IE 1/2 gene
expression and the percentage of cells displaying filaments
compared to dimethyl sulfoxide (DMSO)-treated cells
(Fig. 3A, rows iii and iv, and B). Conversely, cells treated with
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ganciclovir (GCV), an inhibitor of viral DNA synthesis, dis-
played a similar percentage of cells with nuclear F-actin as did
DMSO-treated cells (Fig. 3A, rows iii and v, and B). The con-
centration of GCV used greatly reduced the expression of a late
viral protein, confirming drug efficacy (see Fig. S4 in the sup-
plemental material). Collectively, these results, coupled with
our previous finding that induction occurs in most cells by
8 hpi, suggest that HCMV specifically induces nuclear F-actin
FIG 1 HCMV induces nuclear F-actin. HFFs stably expressing LifeAct-GFP-NLS (green) were either mock infected (rows i and ii) or infected (rows iii to v) with
WT HCMV (MOI of 1). Cells were fixed at the indicated time points, stained with an anti-IE 1/2 antibody (red) and DAPI (blue), and imaged with spinning-disk
confocal microscopy. Images are single Z-sections. Bar, 10 m.
FIG 2 Nuclear F-actin visualization in HSV-1-infected cells. HFFs stably expressing LifeAct-GFP-NLS (green) were either mock infected or infected with
VP26-RFP (red) HSV-1 (MOI of 3). At the time points indicated, cells were fixed, stained with DAPI (blue), and imaged with spinning-disk confocal microscopy.
Images are single Z-sections. Bar, 10 m.
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through the expression of one or more immediate early or
possibly early gene products.
NuclearF-actin localization relative toRCs.Given the impor-
tance of RCs for HCMV replication and previous evidence that
nuclear F-actin facilitates HSV-1 RC movement (24), we won-
dered how actin filaments would localize relative to RCs at differ-
ent stages of HCMV infection. We therefore infected LifeAct-
GFP-NLS-expressing HFFs with HCMV encoding a FLAG-tagged
version of UL44 (44-F; MOI of 1), the viral DNA polymerase
subunit that has previously been shown to concentrate at the pe-
riphery of RCs (3, 4). Cells were then fixed at 24, 48, and 72 hpi and
stained with DAPI and an anti-FLAG antibody, and single optical
sections were imaged using confocal microscopy. By 24 hpi, mul-
tiple small RCs formed within the nucleoplasm, as expected. In
many cases, RCs were found adjacent to actin filaments (Fig. 4,
row i). By later times postinfection (48 to 72 hpi), when RCs had
merged and expanded, nuclear F-actin primarily localized along
the periphery of RCs, with some extending between the RC pe-
riphery and the nuclear rim, and some orienting along the nuclear
rim (Fig. 4, rows ii and iii; Fig. S5 in the supplemental material
contains additional representative images and quantification of
cells containing different filament orientations). These results
raise the possibility of associations between nuclear actin fila-
ments and events occurring at or near the RCs.
Latrunculin A depolymerizes nuclear F-actin and causes de-
fects in viral production andnuclear egress. It has been proposed
that HSV-1 hijacks nuclear F-actin for capsid trafficking during
nuclear egress (26), but a role for F-actin in nuclear egress per se
FIG 3 Determinants of nuclear F-actin induction. (A) Rows i and ii, HFFs stably expressing LifeAct-GFP-NLS (green) were infected with either UV-inactivated
() or mock-UV-inactivated () WT HCMV (MOI of 1). At 24 hpi, cells were fixed, stained with an anti-IE 1/2 antibody (red) and DAPI (blue), and imaged
with spinning-disk confocal microscopy. Rows iii to v, LifeAct-GFP-NLS-expressing HFFs were infected with WT HCMV (MOI of 1) and treated with
cycloheximide (CHX), ganciclovir (GCV), or DMSO vehicle between 0 and 24 hpi. Cells were then fixed and processed as described above. Images are single
Z-sections. Bar, 10m. (B) The percentage of cells with detectable filamentous LifeAct-GFP-NLS staining was quantified for each condition described above (no
UV, n 47; UV, n 50; DMSO, n 55; CHX, n 48; GCV, n 66).
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for any herpesvirus has not been shown. To investigate this issue,
we began by testing whether various concentrations of two widely
used inhibitors of F-actin polymerization, latrunculin A (LatA)
and cytochalasin D (CytoD), antagonize nuclear F-actin in
HCMV-infected HFFs expressing LifeAct-GFP-NLS. In these ex-
periments, we infected cells with WT HCMV (MOI of 5) and at
72 hpi replaced the medium with medium containing LatA, Cy-
toD, or vehicle control (DMSO) for 24 h before fixing cells for
fluorescence microscopy. This allowed us to measure the effects of
actin inhibitors specifically during peak hours of nuclear egress
(72 to 96 hpi). We found that nuclear F-actin was present in most
DMSO-treated LifeAct-GFP-NLS-expressing cells, as expected
(see Fig. S6A, row i, in the supplemental material). While some
nuclear F-actin was evident in cells treated with 4 M LatA, all
cells treated with 8 M LatA exhibited diffuse GFP signal with
little or no nuclear F-actin apparent (see Fig. S6A, rows ii and iii).
Interestingly, even upon treatment with 4 M CytoD (see
Fig. S6A, row iv) or 8M CytoD (data not shown), some cells still
displayed nuclear F-actin. We also noted that the nuclei of cells
treated with all concentrations of LatA and CytoD were signifi-
cantly smaller than those in DMSO-treated cells, consistent with
what was reported with HSV-1 (see Fig. S6A, rows i to iv) (37).
Furthermore, with all concentrations of LatA and CytoD tested,
HFFs displayed a rounded morphology characteristic of cytoplas-
mic F-actin depolymerization (see Fig. S6B). Thus, CytoD failed
to fully depolymerize nuclear F-actin despite exerting effects else-
where in the cell. Collectively, these results indicate that a critical
concentration of LatA is required to antagonize nuclear F-actin
and that CytoD is a less efficacious antagonist.
We then sought to determine whether LatA treatment would
impair HCMV replication and nuclear egress. Using the experi-
mental protocol described above, we found that LatA caused a
dose-dependent decrease in the production of infectious virus,
with the highest defect (~5-fold) occurring with 8 M drug
(Fig. 5A). We also analyzed cells by electron microscopy (EM) to
determine whether LatA treatment inhibits capsid accumulation
in the cytoplasm. Notably, treatment with 8 M LatA caused a
4-fold defect in the mean number of cytoplasmic capsids com-
pared to DMSO-treated cells, which was statistically significant
(P 0.04). Importantly, there was no decrease in the mean num-
ber of nuclear capsids; in fact, there was a 26% increase, which was
significant (P  0.04) (Fig. 5B). There was no significant differ-
ence in total number of capsids (cytoplasmic and nuclear) be-
tween LatA-treated and DMSO-treated cells (P  0.12). As an
additional control, we tested whether LatA treatment affects RC
formation. LifeAct-GFP-NLS-expressing HFFs infected with 44-F
HCMV (MOI of 1) in the presence of 8 M LatA between 0 and
48 hpi exhibited what appeared to be mature RCs in all cells ana-
lyzed (n 10), suggesting that nuclear F-actin is not important for
RC formation or expansion, at least at early stages of infection (see
Fig. S7 in the supplemental material). Thus, our results suggest
that nuclear F-actin depolymerization antagonizes the production
of infectious virus, which is in large part due to specific inhibition
of HCMV nuclear egress.
Nuclear F-actin is important for capsid localization away
from RC-like inclusions. To further interrogate the role of actin
filaments in HCMV nuclear egress, we asked whether nuclear
F-actin depolymerization would impair capsid localization away
from the nuclear interior. EM analysis of HCMV-infected cells in
the abovementioned experiments revealed the formation of
capsid-containing electron-dense inclusions in the interior of the
nucleoplasm that have been considered RCs (38, 39), which we
term RC-like inclusions (Fig. 6A). We therefore calculated the
percentage of capsids located outside these structures, and thus in
closer proximity to the nuclear periphery, in cell sections from the
above-described experiment (Fig. 6B). We found that 18% of cap-
sids were present outside RC-like inclusions in DMSO-treated
cells compared to 6% in LatA-treated cells (3-fold decrease), and
FIG 4 Nuclear F-actin localization relative to RCs. LifeAct-GFP-NLS (green)-expressing HFFs were infected with 44-F HCMV (MOI of 1), fixed at the indicated
time points, stained with an anti-FLAG antibody (red) and DAPI (blue), and imaged with spinning-disk confocal microscopy. Images are single Z-sections. Bar,
10 m.
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this difference was highly significant (P  0.003). We therefore
infer that inhibition of actin polymerization reduces capsid local-
ization away from RCs toward the nuclear periphery.
DISCUSSION
How newly assembled herpesvirus capsids move to the nuclear
periphery is poorly understood and controversial. In this study,
we found that HCMV but not HSV-1 infection leads to a striking
induction of nuclear actin filaments. Induction of nuclear F-actin
began within 6 h following HCMV infection and relied on viral
gene expression but not DNA replication. Interestingly, nuclear
F-actin frequently formed thick structures adjacent to RCs. Later
in infection, filaments were primarily localized along the RC pe-
riphery and between the RC periphery and the nuclear rim, where
they colocalized with capsid protein. Importantly, treatment with
LatA resulted in depolymerization of nuclear F-actin and defects
in viral production, capsid accumulation in the nucleus, and in-
tranuclear capsid localization away from RCs toward the nuclear
rim. We discuss each of these aspects of our results and possible
models by which nuclear F-actin could facilitate capsid movement
from RCs to sites of primary envelopment during HCMV nuclear
egress.
Nuclear F-actin induction. Our finding of nuclear F-actin in-
duction during HCMV infection of HFFs using LifeAct-GFP-NLS
is consistent with previous results with PRV and HSV-1 infection
of mouse neurons and PRV infection of a swine epithelial cell line
(25). In those cases, induction of nuclear F-actin was detected
using serial block-face scanning electron microscopy or phalloi-
din staining (25). Recently, however, the same group found that
MEFs expressing LifeAct-GFP (without an NLS) that were in-
fected with PRV, HSV-1, MCMV, or MHV-68 did not display
nuclear F-actin (27), which is consistent with our inability to de-
tect nuclear F-actin induction in the majority of HSV-1-infected
HFFs. Regardless, certain alpha- and betaherpesviruses are capa-
ble of inducing nuclear F-actin, at least in some cell types. Differ-
ences among viruses and cell types may well explain discrepancies
in reports addressing nuclear F-actin induction.
We also emphasize that it can be difficult to detect nuclear
F-actin using certain techniques that also stain cytoplasmic actin,
as reported by others (30, 32). LifeAct-GFP-NLS affords the ad-
vantage of concentrating actin-binding probe in the nucleus,
which enhances nuclear F-actin visualization and minimizes
staining in the cytoplasm.
We observed what appeared to be a network of individual nu-
clear actin filaments in a small population of mock-infected cells
and in the majority of HCMV-infected cells starting early in infec-
tion, whereas later in infection many filaments appeared thicker.
Our super-resolution microscopy results suggest that these thick
structures are bundles of individual filaments. The exact mecha-
nism by which HCMV infection induces nuclear F-actin and these
thicker structures is unknown. Nevertheless, our results suggest
that one or more viral immediate early or possibly early gene
products promote nuclear F-actin polymerization, as induction
occurs starting around 6 hpi and relies on viral gene expression
but not DNA replication. These viral gene products might induce
nuclear F-actin directly or by effects on host protein expression or
function. Cellular protein candidates that could be affected by
HCMV infection include mDia formin proteins, which are impor-
tant for nuclear F-actin induction upon serum stimulation and
cell spreading (30, 31).
Finally, we note that induction of nuclear F-actin is not con-
fined to herpesviruses, as baculovirus has been shown to use nu-
clear F-actin polymerization for propulsion in a manner similar to
Listeria monocytogenes cytoplasmic motility (41).
LatA inhibition of nuclear F-actin. Even at concentrations
and times of exposure where both LatA and CytoD caused cell
rounding, indicative of cytoplasmic actin depolymerization, LatA
was more efficacious than CytoD at antagonizing HCMV-induced
nuclear F-actin and impaired HCMV production and nuclear
egress. This finding is reminiscent of the previous report that
LatA, but not CytoD, inhibits directed intranuclear movements of
HSV-1 capsids (26). LatA antagonizes F-actin by preventing the
formation of new filaments, while CytoD binds F-actin and pre-
vents additional polymerization (42, 43). It has been speculated
that nuclear F-actin may adopt a structure distinct from cytoplas-
FIG 5 LatA causes defects in viral production and nuclear egress. (A) HFFs
were infected with WT HCMV (MOI of 5). Medium was removed at 72 hpi
and replaced with fresh medium containing the indicated concentrations of
LatA or DMSO vehicle. At 96 hpi, medium was removed for titration to assess
production of infectious virus. The graph shows averages  standard devia-
tions from 3 independent experiments.P values were calculated using one-way
repeated-measures analysis of variance corrected for multiple comparisons
using the Holm-Sidak test. ***, P  0.0003; ****, P  0.0001 (DMSO versus
2 M LatA, P 0.0003; DMSO versus 4 M LatA, P 0.0001; DMSO versus
8 M LatA, P  0.0001). (B) The cell monolayers from above treated with
8 M LatA or DMSO were fixed and processed for EM, and capsids were
counted in the nucleus and cytoplasm of whole-cell sections in 8 cells for each
condition. The horizontal bars indicate the mean number of capsids for each
condition. P values were calculated using the Mann-Whitney test; *, P 0.05
(P 0.04).
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mic F-actin (26, 44), which may account for the different efficacies
of the two drugs. Alternatively, CytoD may not reach its nuclear
target as effectively as LatA.
Using LifeAct-GFP without an NLS, Bosse et al. reported that
nuclear actin rods formed in PRV-infected MEFs after 1 h of treat-
ment with LatA but not CytoD (27). Using LifeAct-GFP-NLS, we
found that treatment with a higher concentration of LatA for a longer
duration depolymerized HCMV-induced nuclear F-actin, in keeping
with its known activity. It was also previously reported that neither
LatA nor CytoD impairs HSV-1 virus yield (37). However, the con-
centrations of LatA (1 to 3M) used in that study were less than the
concentration (4.7 M) used to inhibit directed movements of
HSV-1 capsids (26) and less than the concentration required to de-
polymerize most HCMV-induced nuclear F-actin.
FIG 6 LatA inhibits capsid localization away from RC-like inclusions toward the nuclear periphery. The EM images of whole-cell sections of infected cells
treated with LatA or DMSO vehicle control from Fig. 5 (8 cells for each condition) were analyzed for localization of capsids in or away from RC-like
inclusions. (A) Representative nuclear sections for each condition. White arrows show examples of capsids in RC-like inclusions; black arrows show
examples of capsids outside RC-like inclusions. Bar, 2 m. (B) The percentage of capsids not associated with RC-like inclusions was calculated for each
nucleus and plotted. Bars and the numbers alongside them indicate mean percentages of capsids. P values were calculated using the Mann-Whitney test;
**, P  0.01 (P  0.003).
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Nuclear F-actin and RCs. We observed that HCMV-induced
nuclear F-actin was often located adjacent to RCs. Studies on mul-
tiple DNA viruses have suggested involvement of nuclear F-actin
in RC movement and function (24, 45). As we found that depoly-
merization of nuclear F-actin with LatA did not affect HCMV RC
formation and did not reduce nuclear capsid accumulation, our
data indicate that, at least under the conditions of our studies,
nuclear F-actin is not crucial for capsid assembly or certain steps
preceding it. Thus, the association of F-actin with HCMV RCs
seems more likely to play a role in subsequent steps, such as nu-
clear egress.
ImportanceofF-actin for capsid localization fromRCs to the
nuclear periphery. Using EM, we found that LatA treatment
caused HCMV capsids to accumulate in RC-like inclusions away
from the nuclear rim. It has been reported that inhibition of nu-
clear F-actin affects capsid distribution in PRV-infected nuclei
(25). In that case, depolymerization of nuclear F-actin disrupted
the localization of capsids to small capsid-rich foci, leading these
authors to speculate that filaments serve as a scaffold for capsid
assembly. However, we did not observe a negative effect of LatA
on capsid assembly. We (this study) and others (39) have observed
that HCMV capsids frequently associate with inclusions in the
nuclear interior that are highly reminiscent of RCs visualized with
fluorescence microscopy, suggesting that capsid assembly occurs
in RCs. As we found that LatA treatment led to a decrease in the
percentage of capsids located outside these inclusions and that
capsid protein colocalizes with actin filaments in the nucleus, we
suggest that nuclear F-actin mediates the localization of newly
assembled capsids from RCs toward the nuclear periphery. More-
over, as the magnitudes of the effects of LatA on intranuclear
capsid localization, nuclear egress, and viral production were sim-
ilar, it seems likely that the major role for nuclear F-actin during
HCMV infection is in movement of capsids toward the nuclear
periphery during nuclear egress.
Models. Our data are consistent with the following working
model. Prior to RC formation, nuclear F-actin is induced by one
or more immediate early or early gene products, either directly or
by modulation of host protein synthesis or function. Following
HCMV DNA synthesis at the periphery of RCs, capsid assembly
and packaging occur in and/or near RCs within the nuclear inte-
rior. Subsequent movement of capsids to the nuclear periphery is
a rate-limiting step, as most capsids are present in RC-like inclu-
sions under steady-state conditions. Once capsids are assembled
and packaged with viral DNA in RCs, they move to the nuclear
periphery via an F-actin-dependent mechanism. While our results
are consistent with the proposal that capsid trafficking occurs via a
myosin motor protein(s) walking on F-actin, as suggested for al-
phaherpesviruses (25, 26), our results do not rule out the possibil-
ity that actin dynamics propel capsids or other mechanisms (see
below). Later in infection, when some nuclear F-actin is oriented
along the nuclear rim, capsid movement may occur along the
nuclear periphery to “scan” for gaps in the nuclear lamina so that
capsids can access the inner nuclear membrane (INM) for pri-
mary envelopment. Notably, such a mechanism may be particu-
larly advantageous to HCMV by spatially coordinating nuclear
egress with cytoplasmic maturation in the assembly compart-
ment, which forms distinctly at one side of the nucleus (46).
It has been proposed that alphaherpesvirus infection induces
enlargements of interchromatin domains so that capsids can
move efficiently to the nuclear rim by diffusion, rather than by
directed movements dependent on F-actin (28). It is possible that
HCMV uses a different mechanism for capsid movement to the
nuclear rim than do alphaherpesviruses. Additionally, LatA treat-
ment did not completely ablate capsid accumulation in the cyto-
plasm or capsid localization away from RC-like inclusions. Al-
though that could be due to incomplete efficacy, it remains
possible that some HCMV capsids reach the nuclear periphery by
a non-actin-based mechanism such as diffusion. It also remains
possible that nuclear F-actin induction plays some role in remod-
eling nuclear architecture to enable efficient diffusion of HCMV
capsids toward the nuclear periphery. Thus, further investigation
is required to test whether HCMV capsids undergo directed
movement in the nucleus in an F-actin-dependent manner. Re-
gardless, any model to explain herpesvirus capsid movement to
the nuclear rim should take the results reported here into account.
While the nuclear cytoskeleton has been implicated in numer-
ous processes in both infected and uninfected cells, its structure
and functions are still poorly understood. Thus, how nuclear
F-actin is involved in herpesvirus capsid movement remains an
important subject in the context of not only virology but also cell
biology. Our findings should help pave the way toward a better
understanding of both herpesvirus nuclear egress and, more gen-
erally, actin-based processes in the nucleus.
MATERIALS AND METHODS
Cells and viruses. Human foreskin fibroblast (HFF) cells (ATCC; CRL-
1684) and human embryonic kidney (293T) cells (ATCC; CRL-11268)
were propagated in Dulbecco’s modified Eagle’s medium (DMEM) con-
taining 10% fetal bovine serum (FBS). The HCMV laboratory strain
AD169 was used in all experiments unless otherwise stated. AD169-RV
encoding FLAG-tagged versions of UL53 (53-F) (47) or UL44 (44-F) (48)
was described previously. HSV-1 (KOS) encoding VP26-RFP (49) was a
kind gift from Prashant Desai, Johns Hopkins University. Viruses were
propagated and titrated as described previously (50).
GenerationofLifeAct-GFP-NLS-expressingHFFs.To generate HFFs
stably expressing LifeAct-GFP-NLS, the LifeAct-GFP-NLS insert was re-
moved from its original vector (gift from Robert Grosse, University of
Marburg) and cloned into pLENTI-PGK-Puro vector (Addgene plasmid
catalog no. 19068; gift from Eric Campeau). To generate lentiviruses, 5
105 293T cells/well were plated in a 6-well plate and transfected with
LifeAct-GFP-NLS lentiviral vector along with psPAX2 (Addgene plasmid
catalog no. 12260) and pMDG.2 (catalog no. 12259) packaging plasmids
(gifts from Didier Trono) using Roche Xtreme Gene HD transfection
reagent (according to the manufacturer’s lentivirus production protocol).
Forty-eight hours after transfection, supernatants containing lentiviruses
were harvested and centrifuged at 1,000 g for 5 min to remove cellular
debris. Lentiviral supernatant was filtered, then mixed with Polybrene
(Sigma; final concentration of 8 g/ml), and then used to transduce 3
105 HFFs/well in a 6-well plate. Transduced HFFs were then selected with
puromycin (Sigma; final concentration, 1 g/ml) and expanded.
Immunofluorescence. HFFs (1  105 per well) stably expressing
LifeAct-GFP-NLS were seeded on glass coverslips in a 24-well plate fol-
lowed by either mock infection or infection with HCMV or HSV-1 (as
indicated in the text). At the time points indicated, cells were fixed at room
temperature (RT) in 3.7% formaldehyde–Dulbecco’s phosphate-buffered
saline (DPBS). Cells were then permeabilized at RT in 0.1% Triton
X-100 –DPBS, washed 3 times with DPBS, and blocked overnight in a
mixture of 1% bovine serum albumin (BSA; Sigma) and 5% human se-
rum (Sigma) in DPBS. The following antibodies and dilutions were used
for primary staining: mouse anti-FLAG M2 (Sigma; F1804), 1:500; mouse
anti-IE 1/2 (Virusys; P1215), 1:200; mouse anti-major capsid protein
(MCP) (gift from William Britt), 1:200. Antibodies were diluted in a mix-
ture of 1% BSA-5% human serum in DPBS and added to coverslips for 1 h
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at RT with rocking. Primary antibodies were removed, and coverslips
were washed 3 times with DPBS for 5 min with rocking at RT. The staining
procedure was repeated with the appropriate fluorescently labeled Alexa
Fluor secondary antibodies (Invitrogen), and DAPI was applied in the last
10 min of the secondary antibody incubation. After the final washes, cov-
erslips were mounted on glass slides using ProLong antifade reagent (In-
vitrogen). Imaging was conducted at the Nikon Imaging Center at Har-
vard Medical School using a Nikon Ti spinning-disk confocal laser
microscope equipped with an Orca-AG cooled charge-coupled device
(CCD) camera (Hamamatsu). Postacquisition image analysis was con-
ducted using MetaMorph and ImageJ software packages.
Live-cell imaging.Nuclear F-actin induction was observed in live cells
by infecting HFFs stably expressing LifeAct-GFP-NLS with WT HCMV
(MOI of 3). Directly following infection, cells were imaged at the Nikon
Imaging Center at Harvard Medical School using a Nikon Ti epifluores-
cence microscope equipped with an Orca-ER cooled CCD camera
(Hamamatsu) and an incubation chamber (OkoLab). Images were taken
every 3 min up to 28 hpi.
Super-resolution microscopy. LifeAct-GFP-NLS-expressing HFFs
were infected with WT HCMV (MOI of 3) and fixed at RT in 3.7%
formaldehyde-DPBS at 24 hpi. 3D-SIM data were collected at the Cell
Biology Microscopy Facility at Harvard Medical School using a DeltaVi-
sion OMX V4 Blaze system (GE Healthcare) equipped with a 60/1.42-
numerical-aperture (NA) Plan Apo oil immersion objective lens (Olym-
pus), 488 solid state laser, and a pco.edge 5.5 scientific complementary
metal oxide semiconductor (sCMOS) camera. z-stacks were acquired
with a z-step of 125 nm and with 15 raw images per plane (five phases,
three angles). Spherical aberration was minimized using immersion oil
matching. Super-resolution images were computationally reconstructed
from the raw data sets with a channel-specific measured optical transfer
function (OTF) and a Wiener filter constant of 0.001 to 0.002 using soft-
WoRx 6.1.3 (GE Healthcare).
Cellular fractionation andWesternblot analysis.LifeAct-GFP-NLS-
expressing HFFs (2 105/well) were seeded in a 12-well plate and either
mock infected or infected with WT HCMV (MOI of 1). At 72 hpi, cells
were separated into nuclear and cytoplasmic fractions using an NE-PER
extraction kit (Thermo). For Western blotting, each fraction was mixed
with an equal volume of 2 Laemmli buffer (Bio-Rad), boiled at 95°C for
5 min, and run on a 4 to 20% SDS-polyacrylamide gel (Bio-Rad). Proteins
were then transferred onto a polyvinylidene difluoride (PVDF) mem-
brane, blocked with 5% milk in DPBS-T (DPBS with 0.5% Tween 20), and
probed with primary antibodies overnight at 4°C with rocking. The fol-
lowing antibody dilutions were used: mouse anti--actin (Sigma; A5441),
1:5,000; rabbit anti-GFP (Invitrogen; A11122), 1:1,000; goat anti-lamin B
(Santa Cruz; 6216), 1:200; rabbit anti-GAPDH (Cell Signaling; 14C10),
1:1,000. Membranes were washed 3 times with DPBS-T for 10 min at
room temperature (RT) with rocking. Membranes were then incubated
with secondary antibodies conjugated to horseradish peroxidase (HRP)
(Southern Biotech) at 1:1,000 for 1 h at RT with rocking, followed by
washing. Finally, chemiluminescence solution (Pierce) was added to
membranes and signal was detected with film.
Determinants of nuclear F-actin induction. HFFs (1 105 per well)
stably expressing LifeAct-GFP-NLS were seeded on glass coverslips in a
24-well plate. For UV inactivation, 1 ml of thawed WT HCMV virus stock
was removed from its storage vial and added to a 25-mm dish. The open
dish was placed on ice approximately 12 in. away from a UV lamp for
15 min. Mock UV inactivation was done concurrently using the same
procedure except without UV. Cells were then infected with UV-
inactivated or mock-UV-inactivated HCMV (MOI of 1), fixed at 24 hpi,
and processed for immunofluorescence microscopy as described above.
For drug treatments, cells were infected with WT HCMV (MOI of 1).
After 1.5 h, the viral inoculum was replaced with medium containing
50 mg/ml cycloheximide (CHX), 100 M ganciclovir (GCV), or DMSO
(0.5%). At 24 hpi, cells were fixed and processed for immunofluorescence
microscopy as described above.
F-actin inhibitors. To test the effects of latrunculin A (LatA; Invitro-
gen) and cytochalasin D (CytoD; Sigma), 1  105 HFFs/well stably ex-
pressing LifeAct-GFP-NLS were seeded on glass coverslips in a 24-well
plate and infected with WT HCMV (MOI of 5) on the following day. At
72 hpi, medium was removed and fresh medium containing LatA or Cy-
toD, or DMSO (0.5%; vehicle control), was added back to cells. The next
day (96 hpi), cells were fixed and processed for immunofluorescence assay
(IFA) as described above.
To test the effect of LatA on RC formation, LifeAct-GFP-NLS-
expressing HFFs were seeded on glass coverslips as described above. Cells
were then infected with 44-F HCMV (MOI of 1). After absorption, the
inocula were replaced with 8 M LatA or DMSO (0.5%). At 48 hpi, cells
were fixed and processed for immunofluorescence microscopy as de-
scribed above.
For virus titration and EM assays, 2 105 HFFs/well were seeded in a
12-well plate and infected with WT HCMV (MOI of 5) and drugs were
added as described above. At 96 hpi, medium was removed and titrated to
measure viral production, and the cell monolayers were fixed for EM
analysis to measure nuclear egress and intranuclear capsid distribution as
described in the text.
Transmission electronmicroscopy. EM was utilized to assess nuclear
egress and intranuclear capsid distribution by counting capsids in the
cytoplasm and nuclei and within or outside electron-dense RC-like
inclusions in representative whole-cell sections under the conditions
described above. Processing for image acquisition and data analysis
were performed essentially as described previously (51). The Mann-
Whitney test was applied to calculate P values using GraphPad Prism
software (V6.0d).
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